12 research outputs found

    Pre-harvest low-dose UV-B irradiation improves the accumulation of bioactive component and post-harvest shelf-life of Mesembryanthemum crystallinum

    No full text
    At low doses, UV abiotic stressors benefit plants by stimulating the synthesis of secondary metabolites. This study initially validated the capacity of pre-harvest UV-B treatment to enhance the accumulation of bioactive compounds (mainly phenolics and flavonoids) in M. crystallinum. Subsequently, the effects of varying UV-B levels (0, 0.7, and 1.4 W/m2) on the postharvest quality were investigated by analyzing the temporal dynamics of multiple underlying factors, such as soluble protein and sugar content, weight loss, pigments (carotenoid, chlorophyll), the buildup of reactive oxygen species (ROS; H2O2, O2−), non-enzymatic antioxidants (polyphenols, ascorbic acid), and major antioxidant enzymes activity (CAT and SOD). Evaluations were carried out on excised shoots that dark-stored for 10 days (16 °C, 80 % relative air humidity). The results showed that after low-intensity UV-B treatment (0.7 W/m2), the enzymatic and non-enzymatic antioxidant machinery was more strongly stimulated to offset the accumulation of ROS. While the high-intensity UV-B (1.4 W/m2) led to a decline in soluble protein and sugar reserves over time, accompanied by an increase in ROS., Overall, the findings demonstrate a significantly intensity-dependent beneficial impact of UV-B radiation on M. crystallinum's nutritional value and shelf-life throughout growth

    Pre-Harvest UVB Irradiation Enhances the Phenolic and Flavonoid Content, and Antioxidant Activity of Green- and Red-Leaf Lettuce Cultivars

    No full text
    As a promising environmental protection technology, the application of ultraviolet B irradiation in vegetable production has been widely considered. However, the effect of UVB irradiation varies with different plant varieties. In this study, we investigated the effects of two UVB intensities (0.7, 1.4 W m−2) on the accumulation of phenolics and flavonoids, and antioxidant activity of green-leaf and red-leaf lettuce (Lactuca sativa L.) 7 days prior to harvest. The results indicated that short-term (within 2 days) UVB treatment could promote the increase in total chlorophyll content of red-leaf lettuce and green-leaf lettuce, which increased by 49.8% and 20.6% compared with day zero, respectively, and was beneficial to the synthesis of carotenoids of red-leaf lettuce. Extending UVB exposure time significantly decreased chlorophyll a/b value of green-leaf lettuce from 0.92 to 0.63, and simultaneously increased the accumulation of antioxidant substances such as flavonoids, which were increased by 90.0% and 183.4% compared with day zero for UVB-0.7 and UVB-1.4 treatments of red-leaf lettuce, 84.1% and 110.9% of green-leaf lettuce. In contrast, red-leaf lettuce had a higher accumulation level of secondary metabolites, faster scavenging rate of free radicals, and stronger ability to resist UVB stress. Our results suggest that supplementation of low-dose UVB radiance prior to harvest can improve the secondary metabolite content and antioxidant activity of the two kinds of lettuce. This research provided a theoretical basis for improving lettuce quality by pre-harvest UVB treatment in controlled environmental agriculture

    Effects of RNA methylation on Tumor angiogenesis and cancer progression

    No full text
    Abstract Tumor angiogenesis plays vital roles in the growth and metastasis of cancer. RNA methylation is one of the most common modifications and is widely observed in eukaryotes and prokaryotes. Accumulating studies have revealed that RNA methylation affects the occurrence and development of various tumors. In recent years, RNA methylation has been shown to play an important role in regulating tumor angiogenesis. In this review, we mainly elucidate the mechanisms and functions of RNA methylation on angiogenesis and progression in several cancers. We then shed light on the role of RNA methylation-associated factors and pathways in tumor angiogenesis. Finally, we describe the role of RNA methylation as potential biomarker and novel therapeutic target

    The Prognostic Value of Left Ventricular Entropy From T1 Mapping in Patients With Hypertrophic Cardiomyopathy

    No full text
    Background: The prognostic value of left ventricular (LV) entropy in hypertrophic cardiomyopathy (HCM) is unclear.Objectives: This study aimed to assess the prognostic value of LV entropy from T1 mapping in HCM.Methods: A total of 748 participants with HCM, who underwent cardiovascular magnetic resonance (CMR), were consecutively enrolled. LV entropy was quantified by native T1 mapping. A competing risk analysis and a Cox proportional hazards regression analysis were performed to identify potential associations of LV entropy with sudden cardiac death (SCD) and cardiovascular death (CVD), respectively.Results: A total of 40 patients with HCM experienced SCD, and 65 experienced CVD during a median follow-up of 43 months. Participants with increased LV entropy ( ≥4.06 ) were more likely to experience SCD and CVD (all P &lt; 0.05) in the entire study cohort or the subgroup with low late gadolinium enhancement (LGE) extent ( &lt;15% ). After adjustment for the European Society of Cardiology predictors and the presence of high LGE extent ( ≥15% ), LV mean entropy was an independent predictor for SCD (HR: 1.03; all P &lt; 0.05) by the multivariable competing risk analysis and CVD (HR: 1.06; 95% CI: 1.03-1.09; P &lt; 0.001) by multivariable Cox regression analysis.Conclusions: LV mean entropy derived from native T1 mapping, reflecting myocardial tissue heterogeneity, was an independent predictor of SCD and CVD in participants with HCM. (Cardiac Magnetic Resonance Imaging Clinical Application Registration Study; ChiCTR1900024094)</div

    Prognostic Value of Myocardial T1 Mapping for Predicting Adverse Events in Hypertrophic Cardiomyopathy

    No full text
    BACKGROUND: In patients with hypertrophic cardiomyopathy, the prognostic value of myocardial T1 and extracellular volume fraction for adverse cardiovascular events has not been well defined.METHODS: A total of 663 consecutive participants with hypertrophic cardiomyopathy who underwent 3T cardiovascular magnetic resonance were recruited. The follow-up end points included heart failure (HF)-related death, HF hospitalization, and sudden cardiac death or aborted sudden cardiac death.RESULTS: On Cox proportional hazards regression multivariable analyses, global native T1 excluding late gadolinium enhancement areas (hazard ratio [HR], 1.04 [95% CI, 0.99-1.09]; P=0.094) and global extracellular volume fraction excluding late gadolinium enhancement (HR, 1.02 [95% CI, 0.95-1.10]; P=0.565) were not associated with sudden cardiac death. Conversely, global native T1 (HR, 1.08 per 10 ms increase [95% CI, 1.02-1.16], P=0.014; HR, 1.05 per 10 ms increase [95% CI, 1.01-1.09]; P=0.009) and global extracellular volume fraction (HR, 1.23 per 1% increase [95% CI, 1.11-1.36], P&lt;0.001; HR, 1.10 per 1% increase [95% CI, 1.04-1.16]; P&lt;0.001) were independently associated with HF-related death and the composite end point of HF-related death or HF hospitalization in multivariable Cox models, respectively. CONCLUSIONS: In this study of patients with hypertrophic cardiomyopathy, we found global native T1 and global extracellular volume fraction (excluding late gadolinium enhancement) to be both independently associated with HF-related events, but not sudden cardiac death in multivariable analysis. These findings are hypothesis-generating and will require external validation in larger cohorts.REGISTRATION: URL: https://www.chictr.org.cn; Unique identifier: ChiCTR1900024094.</p

    Table_2_Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer.xlsx

    No full text
    Colorectal cancer (CRC), a seriously threat that endangers public health, has a striking tendency to relapse and metastasize. Redox-related signaling pathways have recently been extensively studied in cancers. However, the study and potential role of redox in CRC remain unelucidated. We developed and validated a risk model for prognosis and recurrence prediction in CRC patients via identifying gene signatures driven by redox-related signaling pathways. The redox-driven prognostic signature (RDPS) was demonstrated to be an independent risk factor for patient survival (including OS and RFS) in four public cohorts and one clinical in-house cohort. Additionally, there was an intimate association between the risk score and tumor immune infiltration, with higher risk score accompanied with less immune cell infiltration. In this study, we used redox-related factors as an entry point, which may provide a broader perspective for prognosis prediction in CRC and have the potential to provide more promising evidence for immunotherapy.</p

    Image_2_Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer.tif

    No full text
    Colorectal cancer (CRC), a seriously threat that endangers public health, has a striking tendency to relapse and metastasize. Redox-related signaling pathways have recently been extensively studied in cancers. However, the study and potential role of redox in CRC remain unelucidated. We developed and validated a risk model for prognosis and recurrence prediction in CRC patients via identifying gene signatures driven by redox-related signaling pathways. The redox-driven prognostic signature (RDPS) was demonstrated to be an independent risk factor for patient survival (including OS and RFS) in four public cohorts and one clinical in-house cohort. Additionally, there was an intimate association between the risk score and tumor immune infiltration, with higher risk score accompanied with less immune cell infiltration. In this study, we used redox-related factors as an entry point, which may provide a broader perspective for prognosis prediction in CRC and have the potential to provide more promising evidence for immunotherapy.</p

    Table_1_Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer.xlsx

    No full text
    Colorectal cancer (CRC), a seriously threat that endangers public health, has a striking tendency to relapse and metastasize. Redox-related signaling pathways have recently been extensively studied in cancers. However, the study and potential role of redox in CRC remain unelucidated. We developed and validated a risk model for prognosis and recurrence prediction in CRC patients via identifying gene signatures driven by redox-related signaling pathways. The redox-driven prognostic signature (RDPS) was demonstrated to be an independent risk factor for patient survival (including OS and RFS) in four public cohorts and one clinical in-house cohort. Additionally, there was an intimate association between the risk score and tumor immune infiltration, with higher risk score accompanied with less immune cell infiltration. In this study, we used redox-related factors as an entry point, which may provide a broader perspective for prognosis prediction in CRC and have the potential to provide more promising evidence for immunotherapy.</p

    Image_1_Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer.tif

    No full text
    Colorectal cancer (CRC), a seriously threat that endangers public health, has a striking tendency to relapse and metastasize. Redox-related signaling pathways have recently been extensively studied in cancers. However, the study and potential role of redox in CRC remain unelucidated. We developed and validated a risk model for prognosis and recurrence prediction in CRC patients via identifying gene signatures driven by redox-related signaling pathways. The redox-driven prognostic signature (RDPS) was demonstrated to be an independent risk factor for patient survival (including OS and RFS) in four public cohorts and one clinical in-house cohort. Additionally, there was an intimate association between the risk score and tumor immune infiltration, with higher risk score accompanied with less immune cell infiltration. In this study, we used redox-related factors as an entry point, which may provide a broader perspective for prognosis prediction in CRC and have the potential to provide more promising evidence for immunotherapy.</p
    corecore